Literature DB >> 12496407

Pre-B cell antigen receptor-mediated signal inhibits CD24-induced apoptosis in human pre-B cells.

Tomoko Taguchi1, Nobutaka Kiyokawa, Kenichi Mimori, Toyo Suzuki, Takaomi Sekino, Hideki Nakajima, Masahiro Saito, Yohko U Katagiri, Nobutake Matsuo, Yoshinobu Matsuo, Hajime Karasuyama, Junichiro Fujimoto.   

Abstract

We previously reported that the cross-linking of cluster of differentiation (CD)24 induces apoptosis in Burkitt's lymphoma cells and that this phenomenon can be enhanced by a B cell Ag receptor (BCR)-mediated signal. In this study, we extend our previous observation and report that CD24 also mediated apoptosis in human precursor-B acute lymphoblastic leukemia cell lines in the pro-B and pre-B stages accompanying activation of multiple caspases. Interestingly, simultaneous cross-linking of pre-BCR clearly inhibited CD24-mediated apoptosis in pre-B cells. We also observed that mitogen-activated protein kinases (MAPKs) were involved in the regulation of this apoptotic process. Pre-BCR cross-linking induced prompt and strong activation of extracellular signal-regulated kinase 1, whereas CD24 cross-linking induced the sustained activation of p38 MAPK, following weak extracellular signal-regulated kinase 1 activation. SC68376, a specific inhibitor of p38 MAPK, inhibited apoptosis induction by CD24 cross-linking, whereas anisomycin, an activator of p38 MAPK, enhanced the apoptosis. In addition, PD98059, a specific inhibitor of MEK-1, enhanced apoptosis induction by CD24 cross-linking and reduced the antiapoptotic effects of pre-BCR cross-linking. Collectively, whether pre-B cells survive or die may be determined by the magnitude of MAPK activation, which is regulated by cell surface molecules. Our findings should be important to understanding the role of CD24-mediated cell signaling in early B cell development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12496407     DOI: 10.4049/jimmunol.170.1.252

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

Review 1.  CD24: from a Hematopoietic Differentiation Antigen to a Genetic Risk Factor for Multiple Autoimmune Diseases.

Authors:  Yixin Tan; Ming Zhao; Bo Xiang; Christopher Chang; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2016-02       Impact factor: 8.667

2.  Impaired cell adhesion, apoptosis, and signaling in WASP gene-disrupted Nalm-6 pre-B cells and recovery of cell adhesion using a transducible form of WASp.

Authors:  Rikiya Sato; Susumu Iiizumi; Eun-Sung Kim; Fumiko Honda; Sang-Kyou Lee; Noritaka Adachi; Hideki Koyama; Shuki Mizutani; Tomohiro Morio
Journal:  Int J Hematol       Date:  2012-02-05       Impact factor: 2.490

3.  Effects of p38α/β inhibition on acute lymphoblastic leukemia proliferation and survival in vivo.

Authors:  A Alsadeq; S Strube; S Krause; M Carlet; I Jeremias; C Vokuhl; S Loges; J A Aguirre-Ghiso; A Trauzold; G Cario; M Stanulla; M Schrappe; D M Schewe
Journal:  Leukemia       Date:  2015-06-24       Impact factor: 11.528

4.  Differential effects of BAFF on B cell precursor acute lymphoblastic leukemia and Burkitt lymphoma.

Authors:  Keiko Onda; Kazutoshi Iijima; Yohko U Katagiri; Hajime Okita; Masahiro Saito; Toshiaki Shimizu; Nobutaka Kiyokawa
Journal:  Int J Hematol       Date:  2010-04-29       Impact factor: 2.490

5.  Clinicopathologic and prognostic significance of CD24 in gallbladder carcinoma.

Authors:  Bo Liu; Yangde Zhang; Mingmei Liao; Zhansheng Deng; Liansheng Gong; Jiarui Jiang; Ling Lynn; Kai Wu; Xiongying Miao
Journal:  Pathol Oncol Res       Date:  2010-06-22       Impact factor: 3.201

6.  Dynamic regulation of CD24 expression and release of CD24-containing microvesicles in immature B cells in response to CD24 engagement.

Authors:  D Craig Ayre; Marcus Elstner; Nicole C Smith; Emily S Moores; Andrew M Hogan; Sherri L Christian
Journal:  Immunology       Date:  2015-07-15       Impact factor: 7.397

7.  CD24 expression is an independent prognostic marker in cholangiocarcinoma.

Authors:  Shefali Agrawal; Boris W Kuvshinoff; Thaer Khoury; Jihnhee Yu; Milind M Javle; Charles LeVea; Jeff Groth; Lionel J Coignet; John F Gibbs
Journal:  J Gastrointest Surg       Date:  2007-04       Impact factor: 3.452

8.  Crosstalk between ROR1 and the Pre-B cell receptor promotes survival of t(1;19) acute lymphoblastic leukemia.

Authors:  Vincent T Bicocca; Bill H Chang; Behzad Kharabi Masouleh; Markus Muschen; Marc M Loriaux; Brian J Druker; Jeffrey W Tyner
Journal:  Cancer Cell       Date:  2012-11-13       Impact factor: 31.743

9.  Elevated hippocampal CD24 in astrocytes participates in neural regeneration possibly via activating SHP2/ERK pathway after experimental traumatic brain injury in mice.

Authors:  Xuan Gao; Han Wang; Yong-Yue Gao; Xiao-Ming Zhou; Tao Tao; Guang-Jie Liu; Yan Zhou; Wei Li; Chun-Hua Hang
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

10.  CD24 is an effector of HIF-1-driven primary tumor growth and metastasis.

Authors:  Shibu Thomas; Michael A Harding; Steven C Smith; Jonathan B Overdevest; Matthew D Nitz; Henry F Frierson; Scott A Tomlins; Glen Kristiansen; Dan Theodorescu
Journal:  Cancer Res       Date:  2012-08-27       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.